A Phase 1, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of Ascending Doses of AZD4547 in Patients with Advanced Solid Tumor Malignancies
Disease/Condition: Advanced Solid Cancers
Principal Investigator: Howard S Hochster |
A Phase I/IIa, First Time in human, open-label dose-escalation study of GSK2636771 in subjects with advanced solid tumors with PTEN deficiency
Disease/Condition: Breast Cancer (ER, PR, and HER2 negative) | Colorectal Cancer | Endometrial Cancer | Gastric Adenocarcinoma | Glioblastoma Multiforme | Head/ Neck Squamous Cell Carcinoma | Melanoma | Non-Small Cell Lung Cancer (NSCLC) | Ovarian Cancer | Prostate Cancer
Principal Investigator: Roy Herbst |
A Pilot Pre-Operative Window Trial of Black Cohosh in Women with Ductal Carcinoma in situ
Disease/Condition: Breast Ductal Carcinoma In Situ (DCIS)
Principal Investigator: Erin Wysong Hofstatter |
A Randomized Controlled Trial of Routine Shave Margins Versus Standard Partial Mastectomy in Breast Cancer Patients
Disease/Condition: Breast Cancer
Principal Investigator: Anees B. Chagpar |
Cardiovascular Risk Assessment in Women with Early Breast Cancer
Disease/Condition: Breast Cancer
Principal Investigator: Jessica Marie Coviello |
HDAC Inhibitor Vorinostat (SAHA) With Capecitabine (Xeloda) Using a New Weekly Dose Regimen for Advanced Breast Cancer
Disease/Condition: Advanced Breast Cancer
Principal Investigator: Abu-Khalaf, Maysa Mahmoud |
Mammosite Breast Brachytherapy Optimization in the Treatment of Breast Carcinoma
Disease/Condition: Breast Neoplasms
Principal Investigator: Weidhaas, Joanne Barnes |
Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients with Advanced Breast and Gastrointestinal Tumors
Disease/Condition: Gastrointestinal Tumors | Metastatic Breast Cancer
Principal Investigator: Gina G Chung |
Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Disease/Condition: Breast Cancer
Principal Investigator: Weidhaas, Joanne Barnes |
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Disease/Condition: Breast Cancer
Principal Investigator: Erin Wysong Hofstatter |
Women's Experience with Triple Negative Breast Cancer
Disease/Condition: Breast Cancer
Principal Investigator: Yasemin Turkman |
